A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1994
10/19/1994	EP0619741A1 Polar lipid composition of plant origin
10/19/1994	EP0619732A1 Biodegradable polymers for cell transplantation
10/19/1994	EP0619731A1 Microcrystalline cellulose spheronization composition
10/19/1994	EP0619730A1 Composition of antineoplastic agents incorporated in micelles
10/19/1994	EP0619704A1 Method and composition for treating tumors having high tyrosinase activity
10/19/1994	EP0546018B1 Pharmaceutical composition of florfenicol
10/18/1994	US5357004 Copolymers of polyaspartic acid
10/18/1994	US5356896 Alkaline stabiling medium
10/18/1994	US5356884 Hetero-branched cyclodextrins
10/18/1994	US5356883 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
10/18/1994	US5356784 Competitive binding; performed without the need for serial dilution steps
10/18/1994	US5356636 Using mixture of oil soluble active material, film forming colloid and reducing sugar
10/18/1994	US5356633 Method of treatment of inflamed tissues
10/18/1994	US5356620 Aqueous solution containing polyvinylpyrrolidone, base, surfactant, preservative; topical treatment of allergic conjunctivitis or rhinitis
10/18/1994	US5356614 Process of preparing microparticulate collagen collagen-based products produced thereby and method of applying same
10/18/1994	US5356467 Controlled release coatings derived from aqueous dispersions of zein
10/18/1994	CA1332570C Method for reducing skin irritation associated with drug/penetration enhancer compositions
10/18/1994	CA1332567C Sustained release pharmaceutical composition
10/18/1994	CA1332495C In situ calcium phosphate minerals -- method and composition
10/17/1994	CA2094203A1 Inhibition of angiogenesis
10/13/1994	WO1994023298A1 Determination of concentration by affinity titration and competitive displacement in drug delivery
10/13/1994	WO1994023050A1 Targeted delivery of genes encoding antisense polyribonucleotides
10/13/1994	WO1994022934A1 Random block copolymers
10/13/1994	WO1994022929A1 Amphoteric copolymer derived from vinylpyridine & acetoxystyrene
10/13/1994	WO1994022885A1 Anticoagulant compounds
10/13/1994	WO1994022883A1 Backbone modified oligonucleotides and their preparation
10/13/1994	WO1994022816A1 Metal chelating compounds
10/13/1994	WO1994022490A1 Conjugates of proteins and bifunctional ligands
10/13/1994	WO1994022485A1 Targeted delivery of genes encoding cellular microsomal enzymes
10/13/1994	WO1994022484A1 Directed delivery of radioprotectants using a receptor specific carrier
10/13/1994	WO1994022483A2 Prodrugs with enhanced penetration into cells
10/13/1994	WO1994022482A1 Compositions including heme-containing proteins and methods relating thereto
10/13/1994	WO1994022481A1 Active-substance patch for releasing estradiol to the skin
10/13/1994	WO1994022471A1 Liquid antithrombin iii preparation and method of stabilizing the same
10/13/1994	WO1994022461A1 Formulation for nasal insulin delivery
10/13/1994	WO1994022455A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	WO1994022454A1 Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
10/13/1994	WO1994022450A1 Nasal pharmaceutical composition containing a progestational agent
10/13/1994	WO1994022445A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
10/13/1994	WO1994022437A2 Method for treating amyloidosis
10/13/1994	WO1994022435A1 A new composition containing selegiline
10/13/1994	WO1994022431A1 Controlled release preparation containing a salt of morphine
10/13/1994	WO1994022429A1 Solid-tumor treatment method
10/13/1994	WO1994022426A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994	WO1994022425A1 Anti-oxidant alkylaryl polyether alcohol polymers
10/13/1994	WO1994021240A3 Superparamagnetic particles, process for producing the same and their use
10/13/1994	WO1994018332A3 Anthrax toxin fusion proteins and uses thereof
10/13/1994	WO1994013325A3 Peptide linkers for improved oligonucleotide delivery
10/13/1994	CA2159916A1 Targeted delivery of genes encoding antisense polyribonucleotides
10/13/1994	CA2159717A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	CA2159649A1 Anticoagulant compounds
10/13/1994	CA2159646A1 Random block copolymers
10/13/1994	CA2159209A1 Pharmaceutical composition containing lipophilic drugs
10/13/1994	CA2158951A1 Nasale pharmaceutical composition containing a progestagenic agent
10/13/1994	CA2158555A1 Amphoteric copolymer derived from vinylpyridine & acetoxystyrene
10/13/1994	CA2157929A1 Determination of concentration by affinity titration and competitive displacement in drug delivery
10/13/1994	CA2156746A1 Active-substance patch for releasing estradiol to the skin
10/13/1994	CA2137258A1 Liquid preparation of antithrombin-iii and stabilizing method therefor
10/13/1994	CA2136970A1 Metal chelating compounds
10/12/1994	EP0619322A2 Prolonged delivery of peptides
10/12/1994	EP0619119A1 Stabilized parathyroid hormone composition
10/12/1994	EP0619118A1 Use of peptide derivatives
10/12/1994	EP0618962A1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
10/12/1994	EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof
10/12/1994	EP0618816A1 Further improvements relating to the radiolabelling of proteins
10/12/1994	EP0618808A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer
10/12/1994	EP0618807A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
10/12/1994	EP0618806A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
10/12/1994	EP0618800A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same
10/12/1994	EP0409870B1 Human growth hormone formulation
10/12/1994	EP0403578B1 Stable pharmaceutical composition
10/12/1994	CN1093283A Compositions and methods for reducing toxicity and increasing the efficacy of drugs
10/12/1994	CN1093255A Vaccines against sterols
10/11/1994	US5354902 Stabilized sorbic acid or salt thereof
10/11/1994	US5354885 Process for preparing ethyl ester of L-DOPA
10/11/1994	US5354853 Phospholipid-saccharide conjugates
10/11/1994	US5354844 Protein-polycation conjugates
10/11/1994	US5354748 Cilastin as an inhibitor of the dipeptidase-like enzyme localized on/in epithelial cells of the small intestine
10/11/1994	US5354561 Process for producing solid active substance forms and products thereof
10/11/1994	US5354560 Supported drugs with increased dissolution rate, and a process for their preparation
10/11/1994	US5354558 Bioerodible contraceptive suppository
10/11/1994	US5354554 Crosslinked antibodies and processes for their preparation
10/11/1994	CA1332412C Stabilized vitamin powder
10/11/1994	CA1332356C Therapeutic agent delivery system
10/11/1994	CA1332349C Process for the production of biologically active peptide preparations suitable for vaginal and rectal administration
10/05/1994	EP0618228A1 Protein with a moiety capable of chelating ions attached thereto
10/05/1994	EP0618191A1 Metal chelating compounds
10/05/1994	EP0617970A2 Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastrointestinal tract
10/05/1994	EP0617958A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions
10/05/1994	EP0617957A1 Oral formulations of ubidecarenone in form of capsules
10/05/1994	EP0617956A2 Anti-inflammatory analgesic plaster containing Piroxicam
10/05/1994	EP0617626A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
10/05/1994	EP0617600A1 Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
10/05/1994	EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use
10/05/1994	CN1092980A Crystalline amifostine compositions and mthods for the preparation and use of same
10/04/1994	US5352715 Injectable ceramic compositions and methods for their preparation and use
10/04/1994	US5352695 Use of lysine pyrrolidone carboxylate and/or of arginine pyrrolidone carboxylate as an antoxidant substance in cosmetic or pharmaceutical compositions
10/04/1994	US5352681 Pharmaceutical enema preparation
10/04/1994	US5352662 Injectable extended release formulations and methods
10/04/1994	US5352461 Self assembling diketopiperazine drug delivery system

1 ... 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 ... 1712